Fei Liu

Title: Biography of Inventor Fei Liu

Introduction

Fei Liu is an innovative inventor based in Cupertino, California. He has made significant contributions to the field of biomedical technology, particularly in the detection and monitoring of cancer through advanced methodologies.

Latest Patents

Fei Liu holds two notable patents. The first patent is titled "Nanoplasmonic quantification of tumor-derived extracellular vesicles in plasma microsamples for detection and treatment monitoring." This patent describes a rapid, ultrasensitive, and inexpensive nanoplasmon-enhanced scattering (nPES) assay that quantifies tumor-derived extracellular vesicles (EVs) from minimal plasma samples. The assay utilizes gold nanospheres and nanorods to enhance the sensitivity and specificity of tumor-derived EV detection. It also serves as a non-invasive method for assessing pancreatic cancer stages and treatment responses, adaptable for other conditions with disease-specific EV proteins. The second patent is for an "Isolation chip for isolating target particles from liquid sample, and device and method for detecting the target particles." This invention includes a reagent reservoir and filtration membranes designed to separate and isolate target particles from bioliquid samples, facilitating the detection of these particles.

Career Highlights

Fei Liu has worked with several prominent organizations, including Wellsim Biomedical Technologies, Inc. and The Methodist Hospital. His work in these institutions has allowed him to develop and refine his innovative technologies.

Collaborations